David Wang
Private Equity Investor bei OrbiMed Advisors Private Equity
Profil
David Wang, M.D., Ph.D., is a Partner and Senior Managing Director on the Asia team, focused on Greater China.
Previously, he was a Managing Director at WI Harper Group, responsible for healthcare investments in China.
He also previously served as Head of Business Development at Siemens Medical Solutions, where he directed corporate strategy and new businesses in molecular diagnostics and diagnostic imaging.
Dr. Wang was a co-founder and EVP at First Genetic Trust, a personalized medicine company.
During his tenure at Bristol-Myers Squibb, Dr. Wang was Chairman of The SNP Consortium Management Committee, the first group of its kind formed by pharmaceutical and technology industries to support the development of personalized medicine.
He received his M.D.
from Peking University Medical School, and his doctorate in Developmental Biology from California Institute of Technology.
Aktive Positionen von David Wang
| Unternehmen | Position | Beginn |
|---|---|---|
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Private Equity Investor | 01.10.2019 |
Ehemalige bekannte Positionen von David Wang
| Unternehmen | Position | Ende |
|---|---|---|
| Healthcare Royalty Partners | Private Equity Investor | 02.09.2019 |
Three Arch Partners
 Three Arch Partners Investment ManagersFinance Three Arch Partners (TAP) is a venture capital firm founded in 1993 by Thomas Fogarty and Wilfred Jaeger. The firm is headquartered in San Mateo, California. | Private Equity Investor | 02.04.2013 |
Access Closure, Inc.
 Access Closure, Inc. Medical SpecialtiesHealth Technology Access Closure, Inc. manufactures and distributes medical devices for cardiovascular and peripheral vascular markets. Its products include Mynx ace, Mynx grip, Mynx sealant technology and flash ostial system. The company was in founded in 2002 by Farhad Khosravi and is headquartered in Santa Clara, CA. | Direktor/Vorstandsmitglied | 01.03.2013 |
Ausbildung von David Wang
| Peking University | Doctorate Degree |
| California Institute of Technology | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Access Closure, Inc.
Access Closure, Inc. Medical SpecialtiesHealth Technology Access Closure, Inc. manufactures and distributes medical devices for cardiovascular and peripheral vascular markets. Its products include Mynx ace, Mynx grip, Mynx sealant technology and flash ostial system. The company was in founded in 2002 by Farhad Khosravi and is headquartered in Santa Clara, CA. | Health Technology |
Three Arch Partners
Three Arch Partners Investment ManagersFinance Three Arch Partners (TAP) is a venture capital firm founded in 1993 by Thomas Fogarty and Wilfred Jaeger. The firm is headquartered in San Mateo, California. | Finance |
OrbiMed Advisors Private Equity
OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Finance |
| Healthcare Royalty Partners | Finance |
